These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16249082)

  • 1. A novel class of sodium/calcium exchanger inhibitors: design, synthesis, and structure-activity relationships of 4-phenyl-3-(piperidin-4-yl)-3,4-dihydro-2(1H)-quinazolinone derivatives.
    Hasegawa H; Muraoka M; Matsui K; Kojima A
    Bioorg Med Chem Lett; 2006 Feb; 16(3):727-30. PubMed ID: 16249082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel class of sodium/calcium exchanger inhibitor: design, synthesis, and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives.
    Hasegawa H; Muraoka M; Ohmori M; Matsui K; Kojima A
    Bioorg Med Chem; 2005 Jun; 13(11):3721-35. PubMed ID: 15863001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives.
    Hasegawa H; Muraoka M; Matsui K; Kojima A
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3471-5. PubMed ID: 14505651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
    Atwal KS; O'Neil SV; Ahmad S; Doweyko L; Kirby M; Dorso CR; Chandrasena G; Chen BC; Zhao R; Zahler R
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4796-9. PubMed ID: 16870436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and structure-activity relationships of 3,4-dihydropyridopyrimidin-2(1H)-one derivatives as a novel class of sodium/calcium exchanger inhibitor.
    Hasegawa H; Muraoka M; Ohmori M; Matsui K; Kojima A
    Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1236-9. PubMed ID: 16204976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of phenoxypyridine derivatives as novel inhibitors of the sodium-calcium exchanger.
    Kuramochi T; Kakefuda A; Yamada H; Sato I; Taguchi T; Sakamoto S
    Bioorg Med Chem; 2004 Oct; 12(19):5039-56. PubMed ID: 15351388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of 6-{4-[(3-fluorobenzyl)oxy]phenoxy}nicotinamide derivatives as a novel class of NCX inhibitors: a QSAR study.
    Kuramochi T; Kakefuda A; Sato I; Tsukamoto I; Taguchi T; Sakamoto S
    Bioorg Med Chem; 2005 Feb; 13(3):717-24. PubMed ID: 15653339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors.
    Birch HL; Buckley GM; Davies N; Dyke HJ; Frost EJ; Gilbert PJ; Hannah DR; Haughan AF; Madigan MJ; Morgan T; Pitt WR; Ratcliffe AJ; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5335-9. PubMed ID: 16202581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR study of new phenylimidazole-pyrazolo[1,5-c]quinazolines as potent phosphodiesterase 10A inhibitors.
    Asproni B; Murineddu G; Pau A; Pinna GA; Langgård M; Christoffersen CT; Nielsen J; Kehler J
    Bioorg Med Chem; 2011 Jan; 19(1):642-9. PubMed ID: 21087867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.
    Pan W; Miao HQ; Xu YJ; Navarro EC; Tonra JR; Corcoran E; Lahiji A; Kussie P; Kiselyov AS; Wong WC; Liu H
    Bioorg Med Chem Lett; 2006 Jan; 16(2):409-12. PubMed ID: 16246560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains.
    Cao SL; Feng YP; Jiang YY; Liu SY; Ding GY; Li RT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1915-7. PubMed ID: 15780632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
    Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
    Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors.
    Kravchenko DV; Kysil VV; Ilyn AP; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1841-5. PubMed ID: 15780618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of benzyloxyphenyl derivatives as a novel class of NCX inhibitors: effects on heart failure.
    Kuramochi T; Kakefuda A; Yamada H; Ogiyama T; Taguchi T; Sakamoto S
    Bioorg Med Chem; 2005 Feb; 13(3):725-34. PubMed ID: 15653340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists.
    Wu WL; Burnett DA; Spring R; Qiang L; Sasikumar TK; Domalski MS; Greenlee WJ; O'Neill K; Hawes BE
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3668-73. PubMed ID: 16690312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel potent and selective integrin alphanubeta3 antagonists--novel synthetic routes to isoquinolinone, benzoxazinone, and quinazolinone acetates.
    Seitz W; Geneste H; Backfisch G; Delzer J; Graef C; Hornberger W; Kling A; Subkowski T; Zimmermann N
    Bioorg Med Chem Lett; 2008 Jan; 18(2):527-31. PubMed ID: 18068982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
    Kravchenko DV; Kuzovkova YA; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Balakin KV; Ivachtchenko AV
    J Med Chem; 2005 Jun; 48(11):3680-3. PubMed ID: 15916416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of an N-(2-aminopyridin-4-ylmethyl)nicotinamide derivative: a potent and orally bioavailable NCX inhibitor.
    Kuramochi T; Kakefuda A; Yamada H; Tsukamoto I; Taguchi T; Sakamoto S
    Bioorg Med Chem; 2005 Jun; 13(12):4022-36. PubMed ID: 15911315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.